Denali Therapeutics Inc.
Compounds, Compositions and Methods
Last updated:
Abstract:
The present disclosure relates generally to compounds and compositions, and their use as kinase inhibitors.
Status:
Application
Type:
Utility
Filling date:
5 Feb 2020
Issue date:
8 Oct 2020